Initiation And Persistence With Antiplatelet Agents Among The Patients With Acute Coronary Syndromes: A Retrospective, Observational Database Study In China

References

• Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with Non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–e228.25260718
   PubMed Web of Science ®Google Scholar
• Ke YN, Chen JL. Guideline for the management of patients with unstable angina or non ST-elevation acute coronary syndromes [in Chinese]. Chin J Cardiol. 2007;35(4):295–304.
   Google Scholar
• Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015;28(2):283–293.25748771
   PubMed Web of Science ®Google Scholar
• Chiang FT, Shyu KG, Wu CJ, et al. Predictors of 1-year outcomes in the Taiwan acute coronary syndrome full spectrum registry. J Formos Med Assoc. 2014;113(11):794–802.24076272
   PubMed Web of Science ®Google Scholar
• Axelsen PH, Bajzer Z, Prendergast FG. Prospective multi-center study of female patients with ST-elevation myocardial infarction in Liaoning province, China. Chin Med J. 2012;125(11):1915–1919.22884053
   PubMed Web of Science ®Google Scholar
• Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177.17213401
   PubMed Web of Science ®Google Scholar
• Hamood H, Hamood R, Green MS, Almog R. Effect of adherence to evidence-based therapy after acute myocardial infarction on all-cause mortality. Pharmacoepidemiol Drug Saf. 2015;24(10):1093.26183333
   PubMed Web of Science ®Google Scholar
• Austin PC, Mamdani MM, Juurlink DN, Alter DA, Tu JV. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality. Am Heart J. 2006;151(5):969–975.16644313
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology. Guideline for the management of patients with non ST-elevation acute coronary syndromes [in Chinese]. Chin J Cardiol. 2012;40(5):353–367.
   Google Scholar
• Yan AT, Yan RT, Tan M, et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J. 2007;154(6):1108–1115.18035083
   PubMed Web of Science ®Google Scholar
• Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: executive summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Duke University Press, 2014: 121–123.
   Google Scholar
• Crawshaw J, Auyeung V, Norton S, et al. Identifying psychosocial predictors of medication non-adherence following acute coronary syndrome: a systematic review and meta-analysis. J Psychosom Res. 2016;90:10.27772555
   PubMed Web of Science ®Google Scholar
• Green A, Pottegård A, Broe A, et al. Initiation and persistence with dual antiplatelet therapy after acute myocardial infarction: a Danish nationwide population-based cohort study. BMJ Open. 2016;6(5):e010880.
   Web of Science ®Google Scholar
• Friedman H, Mollon P, Lian J, et al. Clinical outcomes, health resource use, and cost in patients with early versus late dual or triple anti-platelet treatment for acute coronary syndrome. Am J Cardiovasc Drugs. 2013;13(4):273.23728829
   PubMed Web of Science ®Google Scholar
• Damman P, Hof AWVT, Berg JMT, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group. Neth Heart J. 2017;25(3):181–185.27966184
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology. Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation [in Chinese]. Chin J Cardiol. 2015;43(5):380–393.
   Google Scholar
• Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(19):2411–2420.12435254
   PubMed Web of Science ®Google Scholar
• Prami T, Khanfir H, Deleskog A, et al. Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland. BMJ Open. 2016;6(11):e012604.
   Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(18):1972–1974. doi:10.1056/NEJMra050100
   Google Scholar
• Silcock J, Standage C. Exploring patient adherence to cardiovascular medicines. Br J Nurs. 2013;2(5):223–228.
   Google Scholar
• Bi Y, Gao R, Patel A, et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009;157(3):509–516.e1.19249422
   PubMed Web of Science ®Google Scholar
• Redfern J, Hyun K, Chew DP, et al. Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand. Heart. 2014;100(16):1281–1288.24914060
   PubMed Web of Science ®Google Scholar
• Boggon R, Staa TPV, Timmis A, et al. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction–a hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. 2011;32(19):2376–2386.21875855
   PubMed Web of Science ®Google Scholar
• Pinnarelli L, Mayer F, Bauleo L, et al. Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy. J Cardiovasc Med. 2015;16:3.
   Google Scholar
• Sanfélixgimeno G, Peiró S, Ferreros I, et al. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain. J Manag Care Pharm. 2013;19(3):247.23537459
   PubMed Web of Science ®Google Scholar
• Latry P, Martinlatry K, Lafitte M, et al. Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database. Eurointervention. 2012;7(12):1413.22522552
   PubMed Web of Science ®Google Scholar
• Tianjin Statistics Bureau. Statistical communique of Tianjin on the 2015 national economic and social development. 2016. Available from: http://stats.tj.gov.cn/Item/25858.aspx Accessed November 5, 2019.
   Google Scholar
• Kerr AJ, Turaga M, Grey C, et al. Initiation and maintenance of statins and aspirin after acute coronary syndromes (ANZACS-QI 11). J Prim Health Care. 2016;8(3):238–249.29530207
   PubMedGoogle Scholar
• Claeys MJ, Beauloye C, Pourbaix S, et al. Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort study. Eur Heart J Cardiovasc Pharmacother. 2017;3(4):189–197.28122793
   PubMed Web of Science ®Google Scholar
• He X, Wang Y, Cong H, Lu C, Wu J. Impact of optimal medical therapy at discharge on one-year direct medical costs in patients with acute coronary syndromes: a retrospective, observational database analysis in China. Clin Ther. 2019;41(3):456–465.e2. doi:10.1016/j.clinthera.2019.01.00530770126
   PubMed Web of Science ®Google Scholar
• Wang Y, Cong H, Lu C, et al. Healthcare resource utilization and cost of patients with acute coronary syndromes in Tianjin, China. Value Health. 2017;20(9):A502.
   Web of Science ®Google Scholar
• Sørensen R, Gislason GH, Fosbøl EL, et al. Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study. Br J Clin Pharmacol. 2008;66(6):875.18823305
   PubMed Web of Science ®Google Scholar
• Tangri N, Ferguson TW, Whitlock RH, et al. Long term health outcomes in patients with a history of myocardial infarction: a population based cohort study. PLoS One. 2017;12(7):e0180010.28700669
   PubMed Web of Science ®Google Scholar
• Anand SS, Xie CC, Mehta S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005;46(10):1845–1851. doi:10.1016/j.jacc.2005.05.091.16286169
   PubMed Web of Science ®Google Scholar